O-GHeR(TM) Optimized Growth Hormone Endogenous Releaser
Optimized for Maximal Endogenous Growth Hormone Release, O-GHeR(TM) comprises four peptides in a ratio to optimize a sustained release of growth hormone via enhanced endogenous production.
O-GHeR(TM) Matrix: 10mg GHRP-2 + 5mg CJC-1295 + 5mg Ipamorelin + 0.5mg Proprietary Somatostatin Inhibitory Peptide (pSIP)
10 Item Items
In Stock
Warning: Last items in stock!
Availability date:
O-GHeR Optimized Growth Hormone Endogenous Releaser
O-GHeR(TM) Optimized Growth Hormone Endogenous Releaser
Optimized for Maximal Endogenous Growth Hormone Release, O-GHeR(TM) comprises four peptides in a ratio to optimize a sustained release of growth hormone via enhanced endogenous production.
O-GHeR(TM) Matrix: 10mg GHRP-2 + 5mg CJC-1295 + 5mg Ipamorelin + 0.5mg Proprietary Somatostatin Inhibitory Peptide (pSIP)
Recipient :
* Required fields
or Cancel
O-GHeR(TM) Optimized Growth Hormone Endogenous Releaser
Optimized for Maximal Endogenous Growth Hormone Release for in vivo research applications, O-GHeR(TM) comprises four peptides in a ratio to optimize a sustained release of growth hormone via enhanced endogenous production.
O-GHeR(TM) Optimized Growth Hormone Endogenous Releaser PEPx4 Matrix
10mg GHRP-2 + 5mg CJC-1295 + 5mg Ipamorelin + 0.5mcg Proprietary Somatostatin Inhibitory Peptide (pSIP)
Research Applications: Obesity/Fat Loss, Anabolic/Myotrophic/Anti-Cachexic
Potential Future Human Trials:
Application of dose arms at 410mcg, 615 mcg, and 820mcg once to thrice daily are intended to be trialed.
Format of Supply:
20.5mg Lyophilized Powder in a sterile 3ml vial
USAGE: For Research Use Only! Not For Use in Humans.